Lauren Cole Selected Research

Lysophospholipid Receptors

1/2016

Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation-Novel Paradigm and Therapeutic Potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lauren Cole Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 08/2009
2	Alzheimer Disease (Alzheimer's Disease) 11/2011 - 01/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Inflammation (Inflammations) 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2014
1	Death (Near-Death Experience) 11/2011
1	Amyloid angiopathy 11/2011
1	Dementia (Dementias) 11/2011
1	Down Syndrome (Down's Syndrome) 11/2011
1	Cognitive Dysfunction 01/2010
1	Kidney Neoplasms (Kidney Cancer) 08/2009

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2018 - 08/2009
1	Nucleosomes (Nucleosome)IBA 01/2021
1	Biological ProductsIBA 01/2018
1	Lysophospholipid ReceptorsIBA 01/2016
1	VaccinesIBA 05/2014
1	LigandsIBA 11/2011
1	florbetapirIBA 11/2011
1	Amyloid (Amyloid Fibrils)IBA 11/2011
1	ApolipoproteinsIBA 01/2010
1	Apolipoproteins E (ApoE)IBA 01/2010
1	Apolipoprotein E2IBA 01/2010
1	Conditioned Culture MediaIBA 08/2009
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2009
1	(((4- nitrophenyl)amino)(2,2,4,4- tetramethyl thiochroman-6-yl)amino) methane-1-thioneIBA 08/2009
1	Thymidine PhosphorylaseIBA 08/2009